Familial and hereditary colorectal cancer with emphasis on the hereditary non-polyposis colorectal cancer syndrome

Current Diagnostic Pathology

Volumn 8, Issue 4, 2002, Pages 241-248

  Vasen, H F A ^a   Morreau, H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Familial colon cancer; HNPCC; Immunohistochemistry; Mismatch repair; MSI

Indexed keywords

CANCER DIAGNOSIS; CLINICAL FEATURE; COLORECTAL CARCINOMA; FAMILIAL DISEASE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MEDICAL PRACTICE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PATHOLOGIST; REVIEW; RISK FACTOR;

EID: 0036698174     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2002.0124     Document Type: Review

References (46)

1. Slattery M L, Kerber R A. Family history of cancer and colon cancer risk: the Utah Population Database [published erratum J Natl Cancer Inst 1994 Dec 7;86(23):1802]. J Natl Cancer Inst 1994; 86: 1618-1626.
2. Bussey H J. Familial Polyposis Coli. Baltimore: The Johns Hopkins University Press, 1975.
3. Lynch H T, Smyrk T C, Watson P et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993; 104: 1535-1549.
4. Peltomaki P, Vasen H F. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997; 113: 1146-1158.
5. Miyaki M, Konishi M, Tanaka K et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997; 17: 271-272.
6. Aaltonen L A, Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338: 1481-1487.
7. St John J, McDermott F T, Hopper J L et al. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993; 118: 785-790.
8. Vasen H F, Wijnen J T, Menko F H et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis [published erratum Gastroenterology 1996 Nov;111(5): 1402]. Gastroenterology 1996; 110: 1020-1027.
9. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-218.
10. Lynch H T, de la Chapelle A. Genetic susceptibility to nonpolyposis colorectal cancer. J Med Genet 1999; 36: 801-818.
11. Shashidharan M, Smyrk T, Lin K M et al. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLHI and colorectal cancer from the general population. Dis Colon Rectum 1999; 42: 722-726.
12. Vasen H F, Mecklin J P, Khan P M et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425.
13. Vasen H F, Watson P, Mecklin J P et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453-1456.
14. Wijnen J T, Vasen H F, Khan P M et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998; 339: 511-518.
15. Thibodeau S N, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
16. Aaltonen L A, Peltomaki P, Leach F S et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.
17. Ionov Y, Peinado M A, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558-561.
18. Boland Cr, Thibodeau S N, Hamilton S R et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-5257.
19. Farrington S M, Lin-Goerke J, Ling J et al. Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 1998; 63: 749-759.
20. Liu B, Farrington S M, Petersen G M et al. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1995; 1: 348-352.
21. Wu Y, Berends M J, Mensink R G et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 1999; 65: 1291-1298.
22. Wijnen J, de Leeuw W, Vasen H et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 1999; 23: 142-144.
23. de Leeuw W, Puijenbroek van M, Merx R, Wijnen J Th, Brocker-Vriends H J T, Tops C, Vasen H F A, Cornelisse C J, Morreau H. Bias in the detection of instability of the (C-8) mononucleotide repeat of MSH6 in tumors of HNPCC-patients. Oncogene 2001; 20: 6241-6244.
24. Wilson T M, Ewel A, Duguid I R, Eble J N, Lescoe M K, Fishel R, Kelley M R. Differential cellular expression of the human MSH2 repair enzyme in small and large intestine. Cancer Res 1995; 55: 5146-5150.
25. Leach F S, Polyak K, Burrell M, Johnson K A, Hill D, Dunlop M G, Wyllie A H, Peltomaki P, de la C A, Hamilton S R, Kinzler K W, Vogelstein B. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996; 56: 235-240.
26. Thibodeau S N, French A J, Roche P C, Cunningham J M, Tester D J, Lindor N M, Moslein G, Baker S M, Liskay R M, Burgart L J, Honchel R, Hailing K C. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996; 56: 4836-4840.
27. Marcus V A, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple L K, Hsieh E, Hiruki T, Narod S, Bapat B V, Gallinger S, Redston M. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999; 23: 1248-1255.
28. Curia M C, Palmirotta R, Aceto G, Messerini L, Veri M C, Crognale S, Valanzano R, Ficari F, Fracasso P, Stigliano V, Tonelli F, Casale V, Guadagni F, Battista P, Mariani-Costantini R, Cama A. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer. Cancer Res 1999; 59: 3570-3575.
29. Debniak T, Kurzawski G, Gorski B, Kladny J, Domagala W, Lubinski J. Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer. Eur J Cancer 2000; 36: 49-54.
30. Dieumegard B, Grandjouan S, Sabourin J C, Le Bihan M L, Lefrere I, Bellefqih, Pignon J P, Rougier P, Lasser P, Benard J, Couturier D, Bressac-de Paillerets B. Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer 2000; 82: 871-880.
31. de Leeuw W J F, Dierssen J W, Vasen H F A et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. J Pathol 2000; 192: 328-335.
32. Salahshor S, Koelble K, Rubio C, Lindblom A. Microsatellite instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest 2001; 81: 535-541.
33. Schweizer P, Moisio A L, Kuismanen S A, Truninger K, Vierumaki R, Salovaara R, Arola J, Butzow R, Jiricny J, Peltomaki P, Nystrom-Lahti M. Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer. Cancer Res 2001; 61: 2813-2815.
34. Plaschke J, Krüger S, Pistorius S, Theissig F, Saeger H, Schackert H. Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Int J Cancer, published online 2 Nov 2001.
35. Berends M J, Wu Y, Sijmons R H, Mensink R G, van Der S T, Hordijk-Hos J M, de Vries E G, Hollema H, Karrenbeld A, Buys C H, Der Zee A G, Hofstra R M, Kleibeuker J H. Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 2002; 70: 26-37.
36. Vasen H F, den Hartog J, Menko F H et al. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am J Med 1989; 86: 278-281.
37. Jarvinen H J, Mecklin J P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995; 108: 1405-1411.
38. Jarvinen H J, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-834.
39. Vasen H F, Nagengast F M, Khan P M. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) Lancet 1995; 345: 1183-1184.
40. Vasen H F, van Ballegooijen M, Buskens E et al. A costeffectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998; 82: 1632-1637.
41. Syngal S, Weeks J C, Schrag D et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998; 129: 787-796.
42. Fink D, Aebi S, Howell S B. The role of DNA mismatch repair in drug resistance. Clin Cancer Res 1998; 4: 1-6.
43. Carethers J M, Chauhan D P, Fink D et al. Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 1999; 117: 123-131.
44. Elsaleh H, Josph D, Grieu F et al. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000; 355: 1745-1750.
45. Lerman C, Hughes C, Trock B J et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 1999; 281: 1618-1622.
46. ktan-Collan K, Mecklin J P, Jarvinen H et al. Predictive genetic testing for hereditary nonpolyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 2000; 89: 44-50.